The North America Cell Penetrating Peptide Market would witness market growth of 9.6% CAGR during the forecast period (2023-2030).
The cell-penetrating peptide market has witnessed a surge in interest and innovation, driven by the promising potential of these peptides to facilitate the intracellular delivery of therapeutic molecules. Over the years, cell-penetrating peptides (CPPs) have emerged as versatile tools in drug delivery, opening up new avenues for the targeted delivery of various therapeutic agents into cells. A trajectory of increasing interest and recognition has marked the adoption of cell-penetrating peptides in research and therapeutic development. Initially discovered for their natural ability to traverse cell membranes, CPPs have captured the attention of researchers and industries alike due to their unique ability to facilitate the intracellular delivery of various cargoes, including nucleic acids, proteins, and small molecules.
In addition, researchers have adopted CPPs as valuable tools for studying cellular processes, efficiently enabling probes and biomolecules to live cells. The versatility of CPPs in crossing biological membranes without causing significant cellular damage has made them indispensable in a wide range of experimental settings. CPPs have become essential components of the researcher's toolkit, from fundamental cell biology research to advanced molecular imaging techniques.
Biotechnology investments in the United States can accelerate the development of advanced drug-delivery technologies. CPPs are a part of this landscape, as they have the potential to enhance the delivery of various therapeutic agents, such as peptides, proteins, and nucleic acids. Thus, growing biotechnology investments and R&D in pharmaceutical sector in North America will drive the demand in the regional cell penetrating peptide market.
The US market dominated the North America Cell Penetrating Peptide Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $934.6 Million by 2030. The Canada market is experiencing a CAGR of 12.1% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 11.1% during (2023 - 2030).
Free Valuable Insights: The Cell Penetrating Peptide Market is Predict to reach $2.7 Billion by 2030, at a CAGR of 10.5%
Based on End-use, the market is segmented into Pharmaceutical and Biotechnology Companies, Contract Research Organization (CROs), Hospitals & Clinics, and Others. Based on Application, the market is segmented into Drug Delivery, Gene Delivery, Diagnostics, Molecular Imaging, and Others. Based on Type, the market is segmented into Synthetic CPPs, Protein-derived CPPs, and Chimeric CPPs. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
List of Key Companies Profiled
- Biosynth Ltd
- Creative Peptides
- Cupid Peptide Company Limited
- Alta Bioscience Ltd
- AnaSpec Inc. (Kaneka Eurogentec S.A.) (Kaneka Corporation)
- Peptomyc SL
- PolyPeptide Group AG
- Bachem Holding AG (Ingro Finanz AG)
- Sarepta Therapeutics, Inc.
- Revance Therapeutics, Inc.
North America Cell Penetrating Peptide Market Report Segmentation
By End-use
- Pharmaceutical and Biotechnology Companies
- Contract Research Organization (CROs)
- Hospitals & Clinics
- Others
By Application
- Drug Delivery
- Gene Delivery
- Diagnostics
- Molecular Imaging
- Others
By Type
- Synthetic CPPs
- Protein-derived CPPs
- Chimeric CPPs
By Country
- US
- Canada
- Mexico
- Rest of North America
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Cell Penetrating Peptide Market, by End-use
1.4.2 North America Cell Penetrating Peptide Market, by Application
1.4.3 North America Cell Penetrating Peptide Market, by Type
1.4.4 North America Cell Penetrating Peptide Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Forces Analysis
Chapter 4. North America Cell Penetrating Peptide Market, by End-use
4.1 North America Pharmaceutical and Biotechnology Companies Market, by Country
4.2 North America Contract Research Organization (CROs) Market, by Country
4.3 North America Hospitals & Clinics Market, by Country
4.4 North America Others Market, by Country
Chapter 5. North America Cell Penetrating Peptide Market, by Application
5.1 North America Drug Delivery Market, by Country
5.2 North America Gene Delivery Market, by Country
5.3 North America Diagnostics Market, by Country
5.4 North America Molecular Imaging Market, by Country
5.5 North America Others Market, by Country
Chapter 6. North America Cell Penetrating Peptide Market, by Type
6.1 North America Synthetic CPPs Market, by Country
6.2 North America Protein-derived CPPs Market, by Country
6.3 North America Chimeric CPPs Market, by Country
Chapter 7. North America Cell Penetrating Peptide Market, by Country
7.1 US Cell Penetrating Peptide Market
7.1.1 US Cell Penetrating Peptide Market, by End-use
7.1.2 US Cell Penetrating Peptide Market, by Application
7.1.3 US Cell Penetrating Peptide Market, by Type
7.2 Canada Cell Penetrating Peptide Market
7.2.1 Canada Cell Penetrating Peptide Market, by End-use
7.2.2 Canada Cell Penetrating Peptide Market, by Application
7.2.3 Canada Cell Penetrating Peptide Market, by Type
7.3 Mexico Cell Penetrating Peptide Market
7.3.1 Mexico Cell Penetrating Peptide Market, by End-use
7.3.2 Mexico Cell Penetrating Peptide Market, by Application
7.3.3 Mexico Cell Penetrating Peptide Market, by Type
7.4 Rest of North America Cell Penetrating Peptide Market
7.4.1 Rest of North America Cell Penetrating Peptide Market, by End-use
7.4.2 Rest of North America Cell Penetrating Peptide Market, by Application
7.4.3 Rest of North America Cell Penetrating Peptide Market, by Type
Chapter 8. Company Profiles
8.1 Biosynth Ltd
8.1.1 Company Overview
8.1.2 SWOT Analysis
8.2 Creative Peptides
8.2.1 Company Overview
8.2.2 SWOT Analysis
8.3 Cupid Peptide Company Limited
8.3.1 Company Overview
8.3.2 SWOT Analysis
8.4 Alta Bioscience Ltd
8.4.1 Company Overview
8.4.2 SWOT Analysis
8.5 AnaSpec Inc. (Kaneka Eurogentec S.A.) (Kaneka Corporation)
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 SWOT Analysis
8.6 Peptomyc SL
8.6.1 Company Overview
8.6.2 SWOT Analysis
8.7 PolyPeptide Group AG
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 SWOT Analysis
8.8 Bachem Holding AG (Ingro Finanz AG)
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 SWOT Analysis
8.9 Sarepta Therapeutics, Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Research & Development Expenses
8.10. Revance Therapeutics, Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental Analysis
8.10.4 Research & Development Expenses
8.10.5 SWOT Analysis
TABLE 1 North America Cell Penetrating Peptide Market, 2019 - 2022, USD Million
TABLE 2 North America Cell Penetrating Peptide Market, 2023 - 2030, USD Million
TABLE 3 North America Cell Penetrating Peptide Market, by End-use, 2019 - 2022, USD Million
TABLE 4 North America Cell Penetrating Peptide Market, by End-use, 2023 - 2030, USD Million
TABLE 5 North America Pharmaceutical and Biotechnology Companies Market, by Country, 2019 - 2022, USD Million
TABLE 6 North America Pharmaceutical and Biotechnology Companies Market, by Country, 2023 - 2030, USD Million
TABLE 7 North America Contract Research Organization (CROs) Market, by Country, 2019 - 2022, USD Million
TABLE 8 North America Contract Research Organization (CROs) Market, by Country, 2023 - 2030, USD Million
TABLE 9 North America Hospitals & Clinics Market, by Country, 2019 - 2022, USD Million
TABLE 10 North America Hospitals & Clinics Market, by Country, 2023 - 2030, USD Million
TABLE 11 North America Others Market, by Country, 2019 - 2022, USD Million
TABLE 12 North America Others Market, by Country, 2023 - 2030, USD Million
TABLE 13 North America Cell Penetrating Peptide Market, by Application, 2019 - 2022, USD Million
TABLE 14 North America Cell Penetrating Peptide Market, by Application, 2023 - 2030, USD Million
TABLE 15 North America Drug Delivery Market, by Country, 2019 - 2022, USD Million
TABLE 16 North America Drug Delivery Market, by Country, 2023 - 2030, USD Million
TABLE 17 North America Gene Delivery Market, by Country, 2019 - 2022, USD Million
TABLE 18 North America Gene Delivery Market, by Country, 2023 - 2030, USD Million
TABLE 19 North America Diagnostics Market, by Country, 2019 - 2022, USD Million
TABLE 20 North America Diagnostics Market, by Country, 2023 - 2030, USD Million
TABLE 21 North America Molecular Imaging Market, by Country, 2019 - 2022, USD Million
TABLE 22 North America Molecular Imaging Market, by Country, 2023 - 2030, USD Million
TABLE 23 North America Others Market, by Country, 2019 - 2022, USD Million
TABLE 24 North America Others Market, by Country, 2023 - 2030, USD Million
TABLE 25 North America Cell Penetrating Peptide Market, by Type, 2019 - 2022, USD Million
TABLE 26 North America Cell Penetrating Peptide Market, by Type, 2023 - 2030, USD Million
TABLE 27 North America Synthetic CPPs Market, by Country, 2019 - 2022, USD Million
TABLE 28 North America Synthetic CPPs Market, by Country, 2023 - 2030, USD Million
TABLE 29 North America Protein-derived CPPs Market, by Country, 2019 - 2022, USD Million
TABLE 30 North America Protein-derived CPPs Market, by Country, 2023 - 2030, USD Million
TABLE 31 North America Chimeric CPPs Market, by Country, 2019 - 2022, USD Million
TABLE 32 North America Chimeric CPPs Market, by Country, 2023 - 2030, USD Million
TABLE 33 North America Cell Penetrating Peptide Market, by Country, 2019 - 2022, USD Million
TABLE 34 North America Cell Penetrating Peptide Market, by Country, 2023 - 2030, USD Million
TABLE 35 US Cell Penetrating Peptide Market, 2019 - 2022, USD Million
TABLE 36 US Cell Penetrating Peptide Market, 2023 - 2030, USD Million
TABLE 37 US Cell Penetrating Peptide Market, by End-use, 2019 - 2022, USD Million
TABLE 38 US Cell Penetrating Peptide Market, by End-use, 2023 - 2030, USD Million
TABLE 39 US Cell Penetrating Peptide Market, by Application, 2019 - 2022, USD Million
TABLE 40 US Cell Penetrating Peptide Market, by Application, 2023 - 2030, USD Million
TABLE 41 US Cell Penetrating Peptide Market, by Type, 2019 - 2022, USD Million
TABLE 42 US Cell Penetrating Peptide Market, by Type, 2023 - 2030, USD Million
TABLE 43 Canada Cell Penetrating Peptide Market, 2019 - 2022, USD Million
TABLE 44 Canada Cell Penetrating Peptide Market, 2023 - 2030, USD Million
TABLE 45 Canada Cell Penetrating Peptide Market, by End-use, 2019 - 2022, USD Million
TABLE 46 Canada Cell Penetrating Peptide Market, by End-use, 2023 - 2030, USD Million
TABLE 47 Canada Cell Penetrating Peptide Market, by Application, 2019 - 2022, USD Million
TABLE 48 Canada Cell Penetrating Peptide Market, by Application, 2023 - 2030, USD Million
TABLE 49 Canada Cell Penetrating Peptide Market, by Type, 2019 - 2022, USD Million
TABLE 50 Canada Cell Penetrating Peptide Market, by Type, 2023 - 2030, USD Million
TABLE 51 Mexico Cell Penetrating Peptide Market, 2019 - 2022, USD Million
TABLE 52 Mexico Cell Penetrating Peptide Market, 2023 - 2030, USD Million
TABLE 53 Mexico Cell Penetrating Peptide Market, by End-use, 2019 - 2022, USD Million
TABLE 54 Mexico Cell Penetrating Peptide Market, by End-use, 2023 - 2030, USD Million
TABLE 55 Mexico Cell Penetrating Peptide Market, by Application, 2019 - 2022, USD Million
TABLE 56 Mexico Cell Penetrating Peptide Market, by Application, 2023 - 2030, USD Million
TABLE 57 Mexico Cell Penetrating Peptide Market, by Type, 2019 - 2022, USD Million
TABLE 58 Mexico Cell Penetrating Peptide Market, by Type, 2023 - 2030, USD Million
TABLE 59 Rest of North America Cell Penetrating Peptide Market, 2019 - 2022, USD Million
TABLE 60 Rest of North America Cell Penetrating Peptide Market, 2023 - 2030, USD Million
TABLE 61 Rest of North America Cell Penetrating Peptide Market, by End-use, 2019 - 2022, USD Million
TABLE 62 Rest of North America Cell Penetrating Peptide Market, by End-use, 2023 - 2030, USD Million
TABLE 63 Rest of North America Cell Penetrating Peptide Market, by Application, 2019 - 2022, USD Million
TABLE 64 Rest of North America Cell Penetrating Peptide Market, by Application, 2023 - 2030, USD Million
TABLE 65 Rest of North America Cell Penetrating Peptide Market, by Type, 2019 - 2022, USD Million
TABLE 66 Rest of North America Cell Penetrating Peptide Market, by Type, 2023 - 2030, USD Million
TABLE 67 Key Information – Biosynth Ltd
TABLE 68 Key Information – Creative Peptides
TABLE 69 Key Information – Cupid Peptide Company Limited
TABLE 70 Key Information – Alta Bioscience Ltd
TABLE 71 Key Information – AnaSpec Inc.
TABLE 72 Key Information – Peptomyc SL
TABLE 73 Key Information – PolyPeptide Group AG
TABLE 74 Key Information – Bachem Holding AG
TABLE 75 key information – Sarepta Therapeutics, Inc.
TABLE 76 Key information – Revance Therapeutics, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 North America Cell Penetrating Peptide Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Cell Penetrating Peptide Market
FIG 4 Porter’s Five Forces Analysis – Cell Penetrating peptide market
FIG 5 North America Cell Penetrating Peptide Market share, by End-use, 2022
FIG 6 North America Cell Penetrating Peptide Market share, by End-use, 2030
FIG 7 North America Cell Penetrating Peptide Market, by End-use, 2019 - 2030, USD Million
FIG 8 North America Cell Penetrating Peptide Market share, by Application, 2022
FIG 9 North America Cell Penetrating Peptide Market share, by Application, 2030
FIG 10 North America Cell Penetrating Peptide Market, by Application, 2019 - 2030, USD Million
FIG 11 North America Cell Penetrating Peptide Market share, by Type, 2022
FIG 12 North America Cell Penetrating Peptide Market share, by Type, 2030
FIG 13 North America Cell Penetrating Peptide Market, by Type, 2019 - 2030, USD Million
FIG 14 North America Cell Penetrating Peptide Market share, by Country, 2022
FIG 15 North America Cell Penetrating Peptide Market share, by Country, 2030
FIG 16 North America Cell Penetrating Peptide Market, by Country, 2019 - 2030, USD Million
FIG 17 Swot Analysis: Biosynth Ltd
FIG 18 Swot Analysis: Creative Peptides
FIG 19 Swot Analysis: Cupid Peptide Company Limited
FIG 20 Swot Analysis: Alta Bioscience Ltd.
FIG 21 Swot Analysis: AnaSpec Inc.
FIG 22 Swot Analysis: Peptomyc SL
FIG 23 Swot Analysis: PolyPeptide Group AG
FIG 24 Swot Analysis: Bachem Holding AG
FIG 25 Swot Analysis: Revance Therapeutics, Inc.